PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Psychotropic medication use, including stimulants, in young children leveling off

2013-09-30
(Press-News.org) The use of psychotropic prescription medications to treat ADHD, mood disorders, anxiety and other mental health disorders in very young children appears to have leveled off.

A national study of 2 to 5 year olds shows that overall psychotropic prescription use peaked in 2002-2005, then leveled off from 2006-2009. The researchers also discovered increased use of these medications among boys, white children and those without private health insurance during the 16-year study period, 1994-2009.

The Cincinnati Children's Hospital Medical Center study is published online in the journal Pediatrics.

"The likelihood of receiving a behavioral diagnosis increased in 2006 to 2009, but this was not accompanied by an increased propensity toward psychotropic prescription," says Tanya Froehlich, MD, a pediatrician at Cincinnati Children's and the study's senior author. "In fact, the likelihood of psychotropic use in 2006-2009 was half that of the 1994-1997 period among those with a behavioral diagnosis."

Psychotropic usage decreased from 43 percent of those with one or more behavioral diagnoses in 1994-1997 to 29 percent in 2006-2009.

Commonly prescribed psychotropic medications fall into several categories, including both typical and atypical antipsychotics, antidepressants, antianxiety agents, stimulants and mood stabilizers. The U.S. Food and Drug Administration has approved few of these medications for the preschool age group, yet previous studies documented two to threefold increases in psychotropic prescriptions for preschool children between 1991 and 2001.

The Cincinnati Children's researchers studied data from two national surveys that collect information on patient visits to office-based physician practices and hospital-based outpatient clinics throughout the United States. The researchers studied data on more than 43,000 young children.

It is likely that the use of psychotropic medications leveled off due to numerous warnings issued in the mid to late 2000s. These include a 2004 FDA "black box" warning regarding suicidality risk, 2005 public health advisory regarding potential for cardiovascular risks involving amphetamines, and a 2006 FDA Advisory Committee recommendation (later reversed) for a black box warning on psychostimulants linking these drugs to possible heart problems.

Additional research is needed, says Dr. Froehlich, to determine why boys, white children and those without private health insurance are more likely to receive these medications and to determine their appropriateness.

"Our findings underscore the need to ensure that doctors of very young children who are diagnosing ADHD, the most common diagnosis, and prescribing stimulants, the most common psychotropic medications, are using the most up-to-date and stringent diagnostic criteria and clinical practice guidelines," says Dr. Froehlich. "Furthermore, given the continued use of psychotropic medications in very young children and concerns regarding their effects on the developing brain, future studies on the long-term effects of psychotropic medication use in this age group are essential."

### The study was supported by the National Institute of Mental Health grants K23 MH083881 and K23 MH083027.

About Cincinnati Children's Cincinnati Children's Hospital Medical Center ranks third in the nation among all Honor Roll hospitals in U.S.News and World Report's 2013 Best Children's Hospitals ranking. It is ranked #1 for cancer and in the top 10 for nine of 10 pediatric specialties. Cincinnati Children's, a non-profit organization, is one of the top three recipients of pediatric research grants from the National Institutes of Health, and a research and teaching affiliate of the University of Cincinnati College of Medicine. The medical center is internationally recognized for improving child health and transforming delivery of care through fully integrated, globally recognized research, education and innovation. Additional information can be found at http://www.cincinnatichildrens.org. Connect on the Cincinnati Children's blog, via Facebook and on Twitter.


ELSE PRESS RELEASES FROM THIS DATE:

3 of 4 are aware of ACA individual mandate; only 4 of 10 aware of marketplaces, subsidies

2013-09-30
New York, NY, September 30, 2013—As the key components of the Affordable Care Act roll out this week, more than three-quarters (76%) of U.S. adults are aware of the law's individual mandate, while only four of 10 are aware of the new health insurance marketplaces opening on October 1, or the financial assistance that is available to help people with low or moderate incomes pay their health insurance premiums, according to a new Commonwealth Fund survey. It also finds broad support for expanding Medicaid in all states, with 68 percent of adults saying they are somewhat or ...

Anti-cancer drug T-DM1 benefits women with advanced breast cancer who've failed previous treatments

2013-09-28
Amsterdam, The Netherlands: First results from a phase III clinical trial of the combination drug, T-DM1, show that it significantly improves the length of time before the disease worsens in women with advanced HER2 positive breast cancer whose cancer has recurred or progressed despite previous treatments, including trastuzumab and lapatinib. In a late-breaking presentation to the 2013 European Cancer Congress (ECC2013) [1] today (Saturday), Professor Hans Wildiers will say: "This study shows that even in heavily pre-treated women, 75% of whom had cancer that has spread ...

Longest follow-up of melanoma patients treated with ipilimumab shows some survive up to 10 years

2013-09-28
Patients with advanced melanoma, who have been treated with the monoclonal antibody, ipilimumab, can survive for up to ten years, according to the largest analysis of overall survival for these patients, presented at the 2013 European Cancer Congress (ECC2013) [1] today (Saturday). Professor Stephen Hodi (MD), Assistant Professor of Medicine at the Dana-Farber Cancer Institute (Boston, USA), told the congress: "Our findings demonstrate that there is a plateau in overall survival, which begins around the third year and extends through to the tenth year. "These results ...

Treating chest lymph nodes in early breast cancer patients improves survival

2013-09-28
Giving radiation therapy to the lymph nodes located behind the breast bone and above the collar bone to patients with early breast cancer improves overall survival without increasing side effects. This new finding ends the uncertainty about whether the beneficial effect of radiation therapy in such patients was simply the result of irradiation of the breast area, or whether it treated cancer cells in the local lymph nodes as well, the 2013 European Cancer Congress (ECC2013) [1] will hear today (Saturday). Dr Philip Poortmans, a radiation oncologist from the Institute ...

Hyperfractionated radiotherapy improves survival in head and neck cancer patients

2013-09-28
The use of an intensified form of radiotherapy in patients with locally advanced head and neck cancers can improve overall survival rates compared with standard radiation therapy, according to results from a large study to be presented today (Saturday) at the 2013 European Cancer Congress (ECC2013) [1]. A comparison of altered fractionation radiotherapy (AFRT) with standard fractionation radiotherapy (SFRT) in a meta-analysis of more than 11,000 patients showed an eight percent reduction in the risk of death in the AFRT group, as well as a nine percent reduction in the ...

Researchers demonstrate 'accelerator on a chip'

2013-09-28
In an advance that could dramatically shrink particle accelerators for science and medicine, researchers used a laser to accelerate electrons at a rate 10 times higher than conventional technology in a nanostructured glass chip smaller than a grain of rice. The achievement was reported today in Nature by a team including scientists from the U.S. Department of Energy's (DOE) SLAC National Accelerator Laboratory and Stanford University. "We still have a number of challenges before this technology becomes practical for real-world use, but eventually it would substantially ...

Survival after cancer diagnosis in Europe associated with amount governments spend on health care

2013-09-28
The more an EU (European Union) national government spends on health, the fewer the deaths after a cancer diagnosis in that country, according to new research to be presented to the 2013 European Cancer Congress (ECC2013) [1] today (Sunday) and published simultaneously in the leading cancer journal Annals of Oncology [2]. Researchers will tell the meeting that higher wealth and higher health expenditure are strongly associated both with increased cancer incidence and decreased cancer mortality. In the case of breast cancer, increased health expenditure appears to be ...

Colorectal cancer screening works

2013-09-28
Screening for colorectal cancer (CRC) in European countries is highly effective in reducing mortality from the disease. Some of the resources currently being devoted to breast and prostate screening programmes, where the evidence of effectiveness is much less clear-cut, should be reallocated to the early detection of CRC, the 2013 European Cancer Congress (ECC2013) [1] will hear today (Sunday). Professor Philippe Autier, Vice President, Population Studies, at the International Prevention Research Institute, Lyon, France, will report on results extracted from data on CRC ...

Diabetes increases the risk of developing and dying from breast and colon cancer

2013-09-28
Diabetes is linked to an increased risk of developing cancer, and now researchers have performed a unique meta-analysis that excludes all other causes of death and found that diabetic patients not only have an increased risk of developing breast and colon cancer but an even higher risk of dying from them. Dr Kirstin De Bruijn will tell the 2013 European Cancer Congress (ECC2013) [1], today (Sunday), that previous studies have examined the association between diabetes and dying from cancer but death from specific types of cancer has not been well-studied. "Our meta-analysis ...

Young patients with metastatic colorectal cancer are at high risk of disease progression and death

2013-09-28
Younger patients with colorectal cancer that has spread (metastasised) to other parts of the body represent a high-risk group that is less likely to respond to anti-cancer treatments. Their disease is more likely to progress and they are at greater risk of death than other age groups, according to new research to be presented to the 2013 European Cancer Congress (ECC2013) [1] today (Sunday). An analysis of 20,034 patients in 24 phase III clinical trials [2] for colorectal cancer, of which 695 patients (3%) were younger than 40, showed that the youngest and oldest patients ...

LAST 30 PRESS RELEASES:

Mega-iceberg from Antarctica on collision course with South Georgia: harbinger of things to come?

Beneath the bog: FAU awarded $1.3 million to track carbon and gas flow in peatlands

ETRI to collaborate on semiconductor technology with US Argonne National Laboratory

Unexpected discoveries in study of giraffe gut flora

Not all heart inflammation is the same

New home-based intervention could reduce emergency hospital admissions for older people

Can exercise help colon cancer survivors live as long as matched individuals in the general population?

Unlicensed retailers provide youths with easy access to cannabis in New York City

Scientists track evolution of pumice rafts after 2021 underwater eruption in Japan

The future of geothermal for reliable clean energy

Study shows end-of-life cancer care lacking for Medicare patients

Scented wax melts may not be as safe for indoor air as initially thought, study finds

Underwater mics and machine learning aid right whale conservation

Solving the case of the missing platinum

Glass fertilizer beads could be a sustained nutrient delivery system

Biobased lignin gels offer sustainable alternative for hair conditioning

Perovskite solar cells: Thermal stresses are the key to long-term stability

University of Houston professors named senior members of the National Academy of Inventors

Unraveling the mystery of the missing blue whale calves

UTA partnership boosts biomanufacturing in North Texas

Kennesaw State researcher earns American Heart Association award for innovative study on heart disease diagnostics

Self-imaging of structured light in new dimensions

Study highlights successes of Virginia’s oyster restoration efforts

Optimism can encourage healthy habits

Precision therapy with microbubbles

LLM-based web application scanner recognizes tasks and workflows

Pattern of compounds in blood may indicate severity of gestational hypertension and preeclampsia

How does innovation policy respond to the challenges of a changing world?

What happens when a diet targets ultra-processed foods?

University of Vaasa, Finland, conducts research on utilizing buildings as energy sources

[Press-News.org] Psychotropic medication use, including stimulants, in young children leveling off